期刊文献+

神经肌肉电刺激联合肌电生物反馈治疗产后压力性尿失禁的疗效分析 被引量:7

Curative effect of treating postpartum stress urinary incontinence with electrogymnastics and biofeedback
原文传递
导出
摘要 目的:了解神经肌肉电刺激联合肌电生物反馈治疗对产后妇女压力性尿失禁的临床疗效。方法:2012年1月至2013年3月在我科就诊的产后压力性尿失禁患者168例,其中90例接受了神经肌肉电刺激联合肌电生物反馈治疗,设为治疗组,78例予盆底肌肉锻炼又称为Kegel运动,设为锻炼组。结果:治疗组及锻炼组盆底肌力均有所改善,但治疗组肌力改善情况明显优于锻炼组(P=0.01);治疗组与锻炼组对产后压力性尿失禁的疗效有差异(P=0.000),治疗组疗效优于锻炼组。结论:神经肌肉电刺激联合肌电生物反馈盆底肌训练是一种安全、有效的治疗女性产后压力性尿失禁的方法。 Objective: To obtain the clinical curative effect of treating postpartum stress urinary incontinence with electrogymnastics and biofeedback. Methods: As many as 168 patients were observed during January 2012 to March 2013. They were divided into two groups. One was treatment group including 90 patients treated with electrogymnastics and biofeedback; another was the exercise group including 78 patients treated with pelvic floor muscle training( also named Kegel exercises). Results: The two ways were both effective,but treatment group was better( P = 0. 01). The effects of treating postpartum stress urinary incontinence between the two groups were different and treatment group was better( P = 0. 000). Conclusion: It is deduced that the treatment by electrogymnastics and biofeedback is a safe and effective way to cure the postpartum stress urinary incontinence.
出处 《现代医学》 2014年第9期1034-1036,共3页 Modern Medical Journal
关键词 产后压力性尿失禁 神经肌肉电刺激 肌电生物反馈 盆底肌肉锻炼 postpartum stress urinary incontinence; electrogymnastics; biofeedback; pelvic floor muscle training
  • 相关文献

参考文献5

二级参考文献19

共引文献45

同被引文献98

  • 1Fantl J A,Wyman J F, Mcclish D K, et al. Efficacy of bladder training in old women with urinary incontinence [J].JAMA,1991,265(5):609-613.
  • 2Burgio K L,Locher J L, Goode P S. Combined behavior al and drug therapy for urge incontinence in old women [J]. Am Geriatr Soc,2000,48(4) :37.
  • 3Chess-Williams R. Muscarinic receptors of the urinary bladder= detrusor, urothelial and prejunctional[J]. Auton Autacoid Pharmacol,2002,22(3) = 133-145.
  • 4Chung D E,Te A E, Staskin D R, et al. Efficacy and safety tolterodine extended release and dutasteride in nude overactive bladder patients with prostates ~ 30 grames [J]. Urology,2010,75(5) : 1144-1148.
  • 5Abrams P,Swifts. Solifenacin is effective for the treat ment of OAB dry patients : pooled analysis[J]. Eur Urol,2005,48(3):483 487.
  • 6Cardozo L,Hessdorfer E , Milani R , et al. Solifenacin in the treatment of urgency and other symptoms of over active bladder: results from a randomized, double blind, placebo-controlled, rising-dose trial[J]. BUJ Int, 2008, 102(9):1120-1127.
  • 7Shama A,Goldberg M J, Ceninele B J. Phamacok inet ices and safety of duloxetine,a dual-seroton in and norep inephrine reuptake inhibitor [J]. Clin Phamacol, 2000,40 (2):161-167.
  • 8Aoki K R. A Comparison of the safety margins of botuli- num neurotoxin serotypes A,B,and F in mice[J]. Toxi con,2001,39(12),1815-1820.
  • 9Rapp D E,Lucioni A, Katz E E, et al. Use of botuli num-A tosin for the treatment of refractory overactive bladder symptoms: an initial experierce[J]. Urology, 2004,63(7):1071-1075.
  • 10Kullmann F A,Downs T R, Artim D E, et al. Urothe- lial beta-3 adrenergic receptors in ret bladderEJ]. Neur ourol Urodyn, 2011,30 ( 1 ) .- 144-150.

引证文献7

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部